tetano
Editor, Senior Moderator
Viruses. 2020 Mar 27;12(4). pii: E372. doi: 10.3390/v12040372.
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
Jin Y[SUP]1[/SUP], Yang H[SUP]1[/SUP], Ji W[SUP]1[/SUP], Wu W[SUP]2[/SUP], Chen S[SUP]1[/SUP], Zhang W[SUP]1,[/SUP][SUP]3[/SUP], Duan G[SUP]1[/SUP].
Author information
Abstract
The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.
KEYWORDS:
COVID-19; SARS-CoV-2; epidemiology; pathogenesis; therapeutics
PMID:32230900DOI:10.3390/v12040372
[Indexed for MEDLINE]Free full text
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
Jin Y[SUP]1[/SUP], Yang H[SUP]1[/SUP], Ji W[SUP]1[/SUP], Wu W[SUP]2[/SUP], Chen S[SUP]1[/SUP], Zhang W[SUP]1,[/SUP][SUP]3[/SUP], Duan G[SUP]1[/SUP].
Author information
Abstract
The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.
KEYWORDS:
COVID-19; SARS-CoV-2; epidemiology; pathogenesis; therapeutics
PMID:32230900DOI:10.3390/v12040372
[Indexed for MEDLINE]Free full text